Clinical Trials Browser

Esophageal Neoplasms

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Carcinoma, Hepatocellular

Esophageal Squamous Cell Carcinoma

Breast Neoplasms

Triple Negative Breast Neoplasms

Locally Advanced or Metastatic Solid Tumors

Biliary Tract Neoplasms

Lymphoma, T-Cell, Peripheral

Triple Negative Breast Neoplasms

Pleural Effusion, Malignant

Esophageal Squamous Cell Carcinoma

Recurrence, Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

Rectal Neoplasms

Locally Advanced or Metastatic Gastric Adenocarcinoma

Colorectal Cancer Recurrent

Triple Negative Breast Neoplasms

Neoplasms, Disease Progression

Hepatic Metastasis of Colorectal Cancer

Lymphoma, Non-Hodgkin

Colorectal Neoplasms

Advanced Gastric Cancer

Advanced Gastric Cancer

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular, Stomach Neoplasms

Biliary Tract Neoplasms

Advanced Malignant Solid Tumor

Clinical Trials

Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.

Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment

Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma

Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma

Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

A Umbrella Study in R/R PTCL Guided by Molecular Subtypes

FUTURE

A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion

Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer

Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer

Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer

A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast

Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor

A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457）

Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer

Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant

A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC

Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer

Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs

NRT-01